HF
IRWD icon

HRT Financial’s Ironwood Pharmaceuticals IRWD Stock Holding History

HRT Financial’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-39,844
Closed -$52K – 3582
2025
Q3 		$52K Buy
+39,844
New +$41.2K ﹤0.01% 2601
2024
Q3 		– Sell
-60,271
Closed -$392K – 2769
2024
Q2 		$392K Buy
+60,271
New +$426K ﹤0.01% 1403
2024
Q1 		– Sell
-189,276
Closed -$2.17M – 2674
2023
Q4 		$2.17M Sell
189,276
-52,761
-22% -$522K 0.02% 618
2023
Q3 		$2.33M Buy
242,037
+42,292
+21% +$414K 0.02% 556
2023
Q2 		$2.13M Buy
199,745
+61,578
+45% +$662K 0.02% 588
2023
Q1 		$1.45M Sell
138,167
-183,662
-57% -$2.06M 0.02% 761
2022
Q4 		$3.99M Sell
321,829
-355,404
-52% -$4.03M 0.06% 326
2022
Q3 		$7.02M Buy
+677,233
New +$7.68M 0.08% 208
2021
Q4 		– Sell
-53,077
Closed -$693K – 3606
2021
Q3 		$693K Sell
53,077
-26,107
-33% -$337K ﹤0.01% 1713
2021
Q2 		$1.02M Buy
+79,184
New +$906K 0.01% 1064
2021
Q1 		– Sell
-15,086
Closed -$171K – 2895
2020
Q4 		$171K Buy
+15,086
New +$165K ﹤0.01% 1532
2019
Q4 		– Sell
-12,651
Closed -$108K – 1390
2019
Q3 		$108K Buy
+12,651
New +$123K 0.01% 1237

Other funds holding IRWD

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

HRT Financial's IRWD Position: Q4 2025 in Review

HRT Financial sold out of Ironwood Pharmaceuticals (IRWD) in Q4 2025, closing a stake of 39,844 shares — an estimated $52K sold.

HRT Financial first reported a position in IRWD in Q3 2019 and held it in 12 quarters. The position peaked at $7.02M in Q3 2022. 199 funds tracked by Wall St. Rank hold IRWD as of Q4 2025.

  • HRT Financial reported no remaining Ironwood Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
  • HRT Financial sold 39,844 Ironwood Pharmaceuticals shares in Q4 2025, an estimated $52K.
  • HRT Financial first reported a position in Ironwood Pharmaceuticals in Q3 2019 and held it in 12 quarters.
  • HRT Financial's Ironwood Pharmaceuticals position peaked at $7.02M in Q3 2022.
  • 199 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q4 2025.

Based on HRT Financial's 13F filing for Q4 2025, filed 12 Feb 2026.